AHCO vs IRMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IRMD Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to iRadimed Corporation (IRMD) driven by superior Growth & Margin, Momentum & Technical while AHCO counters with relative strength in Valuation, Options & Structure. Fundamentally, AHCO trades at 7.8x Forward P/E with 3.8% operating margin (+10.9% YoY revenue) versus IRMD at 33.2x Forward P/E and 32.3% operating margin (+14.2% YoY). In options structure, AHCO sits in SURGE (12th %ile IV; Dealer Gamma Walls on Pro) against IRMD sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | AHCO Revenue | IRMD Revenue | AHCO Op. Margin | IRMD Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $350M | $30M | 9.0% | 19.7% | IRMD |
| FY2019 | $530M | $40M | 5.5% | 22.5% | IRMD |
| FY2020 | $1.06B | $30M | 6.8% | -2.4% | AHCO |
| FY2021 | $2.45B | $40M | 9.2% | 23.5% | IRMD |
| FY2022 | $2.97B | $50M | 6.4% | 29.3% | IRMD |
| FY2023 | $3.20B | $70M | -18.7% | 30.6% | IRMD |
| FY2024 | $3.26B | $70M | 8.1% | 30.0% | IRMD |
| FY2025 | $3.24B | $80M | 2.8% | 31.2% | IRMD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AHCO | IRMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $989.8M | $1.0B | Larger Scale | IRMD |
| Trailing P/E Ratio Valuation | 7.8x | 43.5x | Lower Multiple | AHCO |
| Forward P/E Ratio Valuation | 7.8x | 33.2x | Lower Multiple | AHCO |
| Revenue Growth (YoY) Growth | +10.9% | +14.2% | Higher Growth | IRMD |
| Operating Margin (TTM) Profitability | 3.8% | 32.3% | Higher Margin | IRMD |
| Net Profit Margin Profitability | -11.8% | 26.9% | Higher Margin | IRMD |
| Return on Equity (ROE) Capital Efficiency | -28.4% | 23.4% | Higher ROE | IRMD |
| 52-Week Range Position Momentum | 24% ($5โ$13) | 15% ($76โ$108) | Stronger Trend | AHCO |
| Beta / 30D Volatility Risk Regime | 0.17ฮฒ ยท 67% Vol | 0.67ฮฒ ยท 54% Vol | Lower Realized Risk | IRMD |
| Unified Institutional Score Composite Signal | 45.2 / 100 (HOLD) | 42.0 / 100 (HOLD) | Higher Composite | AHCO |